ACE inhibitors can raise bradykinin levels because they block its breakdown. That buildup may irritate sensory nerves in the airways, causing a persistent dry cough, and can also raise the risk of angioedema. Knowing this link helps distinguish it from effects such as low blood pressure.

Multiple Choice

ACE inhibitor commonly causes which side effect due to bradykinin accumulation?

Bradykinin accumulation due to ACE inhibition causes a dry cough. ACE normally degrades bradykinin, so blocking it lets bradykinin build up. That buildup can irritate airway sensory nerves and trigger a persistent cough, and it also raises the risk of angioedema. Other effects like hypotension, headache, or hyperglycemia aren’t driven by bradykinin accumulation in the same way, even though ACE inhibitors can cause BP changes. So the cough is the side effect most directly linked to bradykinin buildup.

Why ACE Inhibitors Can Cause a Persistent Dry Cough

A dry cough can seem like a small price to pay for a medicine that helps protect the heart and blood vessels. Yet for some people taking an ACE inhibitor, that cough becomes persistent, irritating, and hard to ignore. The reason lies in a substance called bradykinin, which can build up when the medicine blocks a key enzyme.

ACE inhibitors are widely used to treat high blood pressure and certain heart conditions. They can be effective and well tolerated, but they may also cause side effects. A dry cough is one of the best-known. Understanding why it happens helps make the effect easier to recognize—and helps explain why a clinician might consider a different medicine if the cough becomes troublesome.

First, what does ACE do?

ACE stands for angiotensin-converting enzyme. As its name suggests, it helps convert one form of angiotensin into another. This matters because angiotensin II narrows blood vessels and encourages the body to hold on to salt and water. Together, those actions can raise blood pressure.

By blocking ACE, ACE inhibitors reduce the amount of angiotensin II the body makes. Blood vessels can relax, and blood pressure may fall. The medicines can also ease the workload on the heart, which is why they may be prescribed for some people with heart failure or other cardiovascular conditions.

But ACE has more than one job. It also helps break down bradykinin, a naturally occurring chemical involved in blood vessel widening and other body processes. When an ACE inhibitor blocks the enzyme, less bradykinin is broken down. Levels can rise.

That’s the important link: the medicine affects the angiotensin system, but it also changes how the body handles bradykinin.

How bradykinin may trigger a cough

When bradykinin builds up, it can irritate sensory nerves in the airways. Those nerves help detect things that might need clearing from the respiratory tract. If they become more sensitive, they can send signals that trigger coughing—even when there’s no infection or obvious irritant to clear.

The cough is often described as dry, meaning it does not bring up mucus. Some people notice a tickle or scratchy feeling in the throat. Others simply find themselves coughing more than usual, often without a clear pattern. It may begin soon after treatment starts, but it can also appear later.

Not everyone taking an ACE inhibitor develops this side effect. People vary in how their bodies respond, and the exact reasons aren’t fully understood. The cough can range from mild to bothersome. For some, it fades over time; for others, it continues until their clinician changes the treatment plan.

This is not the same as a cough caused by a cold. A viral cough often comes with other symptoms, such as a sore throat, congestion, or fever, though not always. An ACE inhibitor-related cough tends to be dry and can persist without those signs. Still, symptoms alone can’t confirm the cause. A healthcare professional can review the timing, the person’s medicines, and other possible explanations.

A cough is different from angioedema

Bradykinin accumulation is also linked to angioedema, a rare but potentially serious reaction. Angioedema involves swelling beneath the skin or in the lining of the mouth and throat. Swelling of the lips, tongue, face, or throat needs urgent medical attention, especially if breathing or swallowing becomes difficult.

A routine dry cough is not the same as angioedema. The two effects are related to bradykinin, but they differ in severity and what they look like. Knowing that distinction matters: a persistent cough deserves a conversation with a clinician, while sudden swelling around the mouth or throat calls for urgent care.

What about blood pressure, headache, or blood sugar?

ACE inhibitors can affect blood pressure—that’s part of how they work. Some people may feel dizzy or lightheaded, especially when starting treatment or after a dose change. Headache can occur for many reasons and may be reported by people taking these medicines, too.

Those effects don’t arise from bradykinin buildup in the same direct way as the dry cough. Hyperglycemia, or high blood sugar, is also not the characteristic effect linked to bradykinin accumulation. The key distinction is that ACE inhibition changes several body processes, while bradykinin offers a specific explanation for the cough.

It’s useful to avoid blaming every new symptom on one medicine. A headache might relate to blood pressure, dehydration, another medication, or something else entirely. The details matter: when a symptom began, how long it lasts, and what else is happening can all help a clinician assess it.

What should someone do about the cough?

Anyone who develops a persistent cough while taking an ACE inhibitor should let their healthcare professional know. They shouldn’t stop or change the medicine on their own. The medicine may be treating an important condition, and a clinician can weigh the benefit against the discomfort and discuss suitable alternatives.

Depending on the person’s health and treatment needs, a clinician may consider another type of medicine. For example, angiotensin receptor blockers (ARBs) affect the angiotensin system in a different way and are less likely to cause the same bradykinin-related cough. They aren’t right for everyone, though, so the choice depends on the individual.

Keeping a simple note of symptoms can help. When did the cough start? Is it dry or does it bring up mucus? Does it disturb sleep or daily activities? These observations can make a medical conversation clearer. They’re also useful because coughs have many causes, from allergies to reflux to respiratory infections.

A small mechanism with a noticeable effect

The ACE inhibitor cough is a good example of how one enzyme can influence more than one pathway. Blocking ACE lowers the production of angiotensin II, which can help lower blood pressure. At the same time, it slows the breakdown of bradykinin. For some people, that extra bradykinin irritates airway nerves and sets off a dry, persistent cough.

The effect can be frustrating, especially when the medicine is doing valuable work. But it’s a known side effect, and people have options to discuss with their care team. Recognizing the pattern—and knowing which symptoms need urgent attention—can turn an annoying mystery into a clearer conversation about safe, effective treatment.